Over-expression of stathmin family members has been reported in hepatocellular carcinoma [31], sarcoma [32], and lung adenocarcinomas [33] and poorly differentiated tumors of the breast and ovaries express higher levels of stathmin than more differentiated and less proliferative tumors [27]. Here, STMN1 is linked to lung adenocarcinoma.